C&G Editor in Chief, Erin Harris
-
Breaking Down The FDA Draft Guidance, "Rare Diseases: Considerations For The Development Of Drugs And Biological Products"
7/24/2024
Raj Bandaru, Associate Director in Regulatory Affairs and U.S. Regulatory Affairs Lead at Accenture provides rich context on parts of the recent FDA Draft Guidance.
-
Regulatory T Cells & Autoimmune Disease
7/9/2024
KSQ's Micah Benson shares information about the company's approach to treating autoimmune disease.
-
What Are Smart mRNAs?
7/1/2024
Strand Therapeutics' programmable, "smart," mRNA therapeutics could deliver precise, potentially curative treatments for solid tumors and hematological malignancies.
-
mRNA Delivering Full-length Dystrophin for DMD
6/24/2024
Elixirgen Therapeutics' Aki Ko shares that is conceivable that delivery of a normal, full-length dystrophin protein would address issues seen with other dystrophin replacement approaches for DMD.
-
New Report Solidifies Greater Philadelphia Region as Global CGT Leader
5/30/2024
A new comprehensive regional snapshot of the CGT industry shows how cell and gene therapy has become one of the most important economic drivers in the Greater Philadelphia Region over the past decade.
-
Pediatric Patient Access With Dr. Bambi Grilley
5/29/2024
ISCT's Chief Regulatory Officer, Dr. Bambi Grilley, Ph.D., shares insight on CGT's global regulatory landscape and the differences between the pediatric and adult patient journey.
-
ISCT 2024 With Dr. Bruce Levine
5/23/2024
Here are highlights, quotes, and more from Episode 76 of Cell & Gene: The Podcast featuring Dr. Bruce Levine.
-
Is A One-Time Cure for HIV on the Horizon?
5/14/2024
Addimmune's CMO, Dr. Marcus Conant, shares information about the company's lead asset, AGT103-T, which has been designed to provide a functional cure for HIV.
-
Cell & Gene: The Podcast Post-Episode Recap: BlueRock Therapeutics' Dr. Ahmed Enayetallah
4/30/2024
This article shares highlights from Cell & Gene: The Podcast featuring BlueRock Therapeutics’ Dr. Ahmed Enayetallah. Heshares impressive data from the Phase 1 study to treat Parkinson's disease.
-
Cell & Gene: The Podcast Post-Episode Recap: Vor Bio's Dr. Robert Ang
4/26/2024
Welcome to my new article series, Cell & Gene: The Podcast Post-Episode Recap, which shares highlights, quotes, and more from recently aired episodes of Cell & Gene: The Podcast.